UK Markets closed

Tonix Pharmaceuticals Holding Corp. (0A4T.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.0900-0.0262 (-22.55%)
At close: 07:11PM BST
Full screen
Previous close0.1162
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0900 - 0.1192
52-week range0.0900 - 0.1192
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)1.29
PE ratio (TTM)N/A
EPS (TTM)-0.2770
Earnings date14 Mar 2022 - 18 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Why Tonix Pharmaceuticals Continued to Plummet Today

    Tonix Pharmaceuticals (NASDAQ: TNXP) is a biotech stock that's having an absolutely awful week. On Wednesday, the company's shares fell sharply for a third straight day, closing more than 13% lower. Investors are clearly shaken by Tonix's current attempt at financial engineering.

  • Motley Fool

    Why Tonix Pharmaceuticals Stock Is Crashing Again Today

    Shares of Tonix Pharmaceuticals Holding (NASDAQ: TNXP) were crashing 22.7% as of 10:54 a.m. ET on Tuesday. This stock split took effect today. Reverse stock splits aren't a sign that things are going well for a company.

  • Motley Fool

    Why Tonix Pharmaceuticals Stock Dived by Over 31% Today

    All stocks have bad days at least once in a while, but Monday for Tonix Pharmaceuticals (NASDAQ: TNXP) was one of the ugliest trading sessions in its history. The company's stock lost nearly one-third of its value after the company announced a financial engineering move that sent investors scrambling for the exits. Tonix announced Monday afternoon that it is effecting a 1-for-32 reverse split of its common stock.